Artal Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $1.13M | Hold |
|
|||||
2022
Q4 | $749K | Hold |
|
|||||
2022
Q3 | $1.35M | Hold |
|
|||||
2022
Q2 | $2.17M | Hold |
|
|||||
2022
Q1 | $2.07M | Hold |
|
|||||
2021
Q4 | $3.5M | Hold |
|
|||||
2021
Q3 | $6.38M | Hold |
|
|||||
2021
Q2 | $12.3M | Hold |
|
|||||
2021
Q1 | $16.6M | Buy |
|
|||||
2020
Q4 | $15.5M | Hold |
|
|||||
2020
Q3 | $10.2M | Buy |
|
|||||
2020
Q2 | $5.38M | Sell |
|
|||||
2020
Q1 | $3.1M | Hold |
|
|||||
2019
Q4 | $5.71M | Sell |
|
|||||
2019
Q3 | $7.09M | Sell |
|
|||||
2019
Q2 | $7.01M | Hold |
|
|||||
2019
Q1 | $8.54M | Buy |
|